Van ECK Associates Corp Decreases Holdings in Agilent Technologies, Inc. $A

Van ECK Associates Corp decreased its position in Agilent Technologies, Inc. (NYSE:A) by 18.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,407,227 shares of the medical research company’s stock after selling 310,807 shares during the quarter. Van ECK Associates Corp owned 0.50% of Agilent Technologies worth $186,922,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of A. Fiduciary Trust Co raised its position in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares during the period. Sapient Capital LLC boosted its position in Agilent Technologies by 4.2% during the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after buying an additional 85 shares during the period. Plan A Wealth LLC boosted its position in Agilent Technologies by 3.2% during the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after buying an additional 92 shares during the period. UNIVEST FINANCIAL Corp grew its stake in shares of Agilent Technologies by 1.3% during the second quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock valued at $949,000 after buying an additional 93 shares during the last quarter. Finally, IHT Wealth Management LLC increased its holdings in shares of Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after buying an additional 96 shares during the period.

Agilent Technologies Trading Down 2.0%

A opened at $154.47 on Friday. The company has a quick ratio of 1.62, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $163.75. The stock has a market cap of $43.63 billion, a PE ratio of 30.41, a PEG ratio of 2.72 and a beta of 1.25. The business has a 50 day moving average of $140.30 and a 200-day moving average of $127.04.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 6.2 earnings per share for the current fiscal year.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Analyst Ratings Changes

Several analysts have weighed in on the company. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Barclays raised their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Thursday. Citigroup boosted their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Wells Fargo & Company reduced their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.